Concepedia

Andrew Scanga

AS

13

Publications

1.8K

Citations

13

H-Index

2003

Active since

Affiliations

Indiana University – Purdue University Indianapolis(Current)

Indiana University School of Medicine

Vanderbilt University Medical Center

The University of Texas MD Anderson Cancer Center

Texas Liver Institute

Andrew Scanga is an author at Indiana University – Purdue University Indianapolis specializing in hepatology, medicine, and liver physiology.

ORCID

Top concepts

Publications per year

2003–2020

13

Publications

13

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 438 citations

, , +9

Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension

Naga Chalasani, Manal F. Abdelmalek, Guadalupe García–Tsao et al. · Gastroenterology · 2019 · 326 citations · Full text

The Role of Focal Adhesion Kinase-Phosphatidylinositol 3-Kinase-Akt Signaling in Hepatic Stellate Cell Proliferation and Type I Collagen Expression

Shimon Reif, Alon Lang, Jeffery N. Lindquist et al. · Journal of Biological Chemistry · 2003 · 292 citations · Full text

DNase I-hypersensitive sites enhance α1(I) collagen gene expression in hepatic stellate cells

Yutaka Yata, Andrew Scanga, Andrea Gillan et al. · Hepatology · 2003 · 201 citations · Full text

Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension

Guadalupe García–Tsao, Jaime Bosch, Zeid Kayali et al. · Journal of Hepatology · 2019 · 152 citations · Full text

, , +8

Rows per page

1–5 of 13